I. Adamec, B. Barun, T. Gabeli?, I. Zadro, and M. Habek, Delay in the diagnosis of multiple sclerosis in Croatia, Proceedings of the 6th, 2013.

, Dubrovnik International Conference on Multiple Sclerosis, vol.1, pp.70-72, 2012115-05.


E. Agardh, P. Allebeck, J. Hallqvist, T. Moradi, and A. Sidorchuk, Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis, International Journal of Epidemiology, vol.40, pp.804-818, 2011.

R. Aharoni, The mechanism of action of glatiramer acetate in multiple sclerosis and beyond, Autoimmunity Reviews, vol.12, pp.543-553, 2013.


V. L. Allgar and R. D. Neal, Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer, Br J Cancer, vol.92, pp.1959-70, 2005.

A. Ascherio and K. L. Munger, Environmental risk factors for multiple sclerosis. Part I: The role of infection, Annals of Neurology, vol.61, pp.288-299, 2007.

D. J. Barker, K. M. Godfrey, C. Fall, C. Osmond, P. D. Winter et al., Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease, BMJ, vol.303, pp.671-675, 1991.


J. A. Baron, L. Vecchia, C. Levi, and F. , The antiestrogenic effect of cigarette smoking in women, Am. J. Obstet. Gynecol, vol.162, pp.502-514, 1990.

M. Bartley and I. Plewis, Does health-selective mobility account for socioeconomic differences in health? Evidence from England and Wales, 1971 to 1991, J Health Soc Behav, vol.38, pp.376-386, 1997.

G. W. Beebe, J. F. Kurtzke, L. T. Kurland, T. L. Auth, and B. Nagler, Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II, Neurology, vol.17, pp.1-17, 1967.

L. Belbasis, V. Bellou, E. Evangelou, J. P. Ioannidis, and I. Tzoulaki, Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and metaanalyses, The Lancet Neurology, vol.14, issue.14, pp.70267-70271, 2015.

V. M. Beltran, K. M. Harrison, H. I. Hall, and H. D. Dean, Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB, Public Health Rep, vol.126, pp.41-53, 2011.

C. Binquet, C. Quantin, G. Le-teuff, J. F. Pagliano, M. Abrahamowicz et al., The Prognostic Value of Initial Relapses on the Evolution of Disability in Patients with Relapsing-Remitting Multiple Sclerosis, Neuroepidemiology, vol.27, pp.45-54, 2006.


K. Bjørnevik, T. Riise, E. Benjaminsen, E. G. Celius, O. P. Dahl et al., Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study, Mult Scler, vol.22, pp.104-111, 2016.

K. Bjørnevik, T. Riise, M. Cortese, T. Holmøy, M. T. Kampman et al., Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study, Mult. Scler, vol.22, pp.104-111, 2016.

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

R. Bove, A. Musallam, Z. Xia, N. Baruch, S. Messina et al., Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity, Multiple Sclerosis and Related Disorders, vol.8, pp.136-140, 2016.

N. E. Breslow and N. E. Day, Statistical methods in cancer research. Volume II--The design and analysis of cohort studies, IARC Sci. Publ, pp.1-406, 1987.

F. B. Briggs, M. C. Green, and M. L. Ritterman-weintraub, Role of socioeconomic position in multiple sclerosis etiology, Neurodegener Dis Manag, vol.5, pp.333-343, 2015.


F. B. Briggs, B. S. Acuña, L. Shen, K. H. Bellesis, P. P. Ramsay et al., Adverse socioeconomic position during the life course is associated with multiple sclerosis, J Epidemiol Community Health, vol.68, pp.622-629, 2014.

F. B. Briggs, N. R. Thompson, and D. S. Conway, Prognostic factors of disability in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders, vol.30, pp.9-16, 2019.

B. Brochet, J. Sèze, . De, C. Lebrun-frenay, H. Zéphir et al., La sclérose en plaques -Clinique et thérapeutique, 2017.

P. Browne, D. Chandraratna, C. Angood, H. Tremlett, C. Baker et al., Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity, Neurology, vol.83, pp.1022-1024, 2014.

W. J. Brownlee, J. K. Swanton, K. A. Miszkiel, D. H. Miller, and O. Ciccarelli, Should the symptomatic region be included in dissemination in space in MRI criteria for MS?, Neurology, vol.87, pp.680-683, 2016.

J. Bryere, O. Dejardin, V. Bouvier, M. Colonna, A. V. Guizard et al., Socioeconomic environment and cancer incidence: a French population-based study in Normandy, BMC Cancer, vol.14, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00950127

J. Bryere, C. Pornet, N. Copin, L. Launay, G. Gusto et al., Assessment of the ecological bias of seven aggregate social deprivation indices, BMC Public Health, vol.17, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01438556

R. J. Buchanan, A. Stuifbergen, B. J. Chakravorty, S. Wang, L. Zhu et al., Urban/rural differences in access and barriers to health care for people with multiple sclerosis, J Health Hum Serv Adm, vol.29, pp.360-375, 2006.

R. J. Buchanan, S. Wang, A. Stuifbergen, B. J. Chakravorty, L. Zhu et al., Urban/rural differences in the use of physician services by people with multiple sclerosis, NeuroRehabilitation, vol.21, pp.177-187, 2006.

J. Burks, Multiple sclerosis care: an integrated disease-management model, J Spinal Cord Med, vol.21, pp.113-116, 1998.

J. M. Burton, P. W. O'connor, M. Hohol, and J. Beyene, Oral versus intravenous steroids for treatment of relapses in multiple sclerosis, Cochrane Database of Systematic Reviews, 2012.

E. Cadum, G. Costa, A. Biggeri, and M. Martuzzi, Deprivation and mortality: a deprivation index suitable for geographical analysis of inequalities, 1999.

, Epidemiol Prev, vol.23, pp.175-187

F. Calocer, O. Dejardin, K. Droulon, G. Launoy, and G. Defer, Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients, PLOS ONE, vol.13, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01856017

I. Casetta, E. Granieri, S. Malagù, M. R. Tola, E. Paolino et al., Environmental risk factors and multiple sclerosis: a communitybased, case-control study in the province of Ferrara, Italy. Neuroepidemiology, vol.13, pp.120-128, 1994.

. Les and . Bibliographiques,

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

E. Chen and G. E. Miller, Socioeconomic status and health: mediating and moderating factors, Annu Rev Clin Psychol, vol.9, pp.723-749, 2013.

E. Cocco, C. Sardu, G. Spinicci, L. Musu, R. Massa et al., Influence of treatments in multiple sclerosis disability: A cohort study, Mult Scler, vol.21, pp.433-441, 2015.

C. Confavreux and S. Vukusic, Natural history of multiple sclerosis: a unifying concept, Brain, vol.129, pp.606-616, 2006.

C. Confavreux and S. Vukusic, Age at disability milestones in multiple sclerosis, Brain, vol.129, pp.595-605, 2006.

C. Confavreux, S. Vukusic, T. Moreau, and P. Adeleine, Relapses and progression of disability in multiple sclerosis, N Engl J Med, vol.343, pp.1430-1438, 2000.


J. Correale and M. I. Gaitán, Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection, Acta Neurologica Scandinavica, vol.132, pp.46-55, 2015.

M. Cortese, T. Riise, K. Bjørnevik, K. Myhr, and M. S. Group, Body size and physical exercise, and the risk of multiple sclerosis, Multiple Sclerosis Journal, 2017.

K. H. Costenbader and E. W. Karlson, Cigarette smoking and autoimmune disease: what can we learn from epidemiology?, Lupus, vol.15, pp.737-745, 2006.


F. Cotton, S. Kremer, S. Hannoun, S. Vukusic, and V. Dousset, OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol, J Neuroradiol, vol.42, pp.133-140, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01378309

P. K. Coyle and H. P. Hartung, Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose-and frequency-dependent effects on clinical response, Mult. Scler, vol.8, pp.2-9, 2002.

A. Creange, M. Debouverie, V. Jaillon-riviere, F. Taithe, D. Liban et al., Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks, Multiple Sclerosis, vol.15, pp.1085-1091, 2009.

C. Cubbin, K. Sundquist, H. Ahlén, S. Johansson, M. A. Winkleby et al., Neighborhood deprivation and cardiovascular disease risk factors: protective and harmful effects, Scand J Public Health, vol.34, pp.228-237, 2006.


G. Dahlgren and M. Whitehead, Policies and strategies to promote social equity in health 69

T. De-saint-pol and F. Marical, La complémentaire santé: une généralisation qui n'efface pas les inégalités, 2007.

M. Debouverie, C. Lebrun, S. Jeannin, S. Pittion-vouyovitch, T. Roederer et al., More severe disability of North Africans vs Europeans with multiple sclerosis in France, Neurology, vol.68, pp.29-32, 2007.

C. A. Dendrou, L. Fugger, and M. A. Friese, Immunopathology of multiple sclerosis, Nat Rev Immunol, vol.15, pp.545-558, 2015.

A. Derakhshan, J. Miller, D. Lubelski, A. S. Nowacki, B. J. Wells et al., The Impact of Socioeconomic Status on the Utilization of Spinal Imaging, vol.77, pp.746-754, 2015.


M. B. D'hooghe, P. Haentjens, A. Van-remoortel, J. De-keyser, and G. Nagels, Selfreported levels of education and disability progression in multiple sclerosis, Acta Neurol Scand, vol.134, pp.414-419, 2016.

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

D. Pauli, F. Reindl, M. Ehling, R. Schautzer, F. Gneiss et al., Smoking is a risk factor for early conversion to clinically definite multiple sclerosis, Mult. Scler, vol.14, pp.1026-1030, 2008.

A. V. Diez-roux, Neighborhoods and Health: What Do We Know? What Should We Do?, Am J Public Health, vol.106, pp.430-431, 2016.

N. Duchovskiene, D. Mickeviciene, G. Jurkeviciene, B. Dirziuviene, and R. Balnyte, Factors associated with adherence to disease modifying therapy in multiple sclerosis: An observational survey from a referral center in Lithuania, Mult Scler Relat Disord, vol.13, pp.107-111, 2017.

G. J. Duncan, M. C. Daly, P. Mcdonough, and D. R. Williams, Optimal Indicators of Socioeconomic Status for Health Research, Am J Public Health, vol.92, pp.1151-1157, 2002.

S. E. Dunn, E. Gunde, and H. Lee, Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease, Curr Top Behav Neurosci, vol.26, pp.57-86, 2015.

E. Leray, Excess mortality in patients with relapsing-onset multiple, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02363491

J. M. Encinas, L. Manganas, and G. Enikolopov, Nitric oxide and multiple sclerosis, Curr Neurol Neurosci Rep, vol.5, pp.232-238, 2005.

E. Timothy, Challenging Inequities in Health: From Ethics to Action, 2001.

M. F. Farez, M. P. Fiol, M. I. Gaitán, F. J. Quintana, and J. Correale, Sodium intake is associated with increased disease activity in multiple sclerosis, J Neurol Neurosurg Psychiatry, vol.86, pp.26-31, 2015.

M. Filippi, M. A. Rocca, O. Ciccarelli, N. De-stefano, N. Evangelou et al., MRI criteria for the diagnosis of Multiple Sclerosis: MAGNIMS consensus guidelines, Lancet Neurol, vol.15, pp.292-303, 2016.

S. Fosse-edorh, A. Fagot-campagna, B. Detournay, H. Bihan, A. Gautier et al., Type 2 diabetes prevalence, health status and quality of care among the North African immigrant population living in France, Diabetes Metab, vol.40, pp.143-150, 2014.

A. Fromont, C. Binquet, E. A. Sauleau, I. Fournel, A. Bellisario et al., Geographic variations of multiple sclerosis in France, Brain, vol.133, pp.1889-1899, 2010.

A. Fromont, C. Binquet, E. A. Sauleau, I. Fournel, R. Despalins et al., National estimate of multiple sclerosis incidence in France, Mult Scler, vol.18, pp.1108-1115, 2001.


P. Ghadirian, B. Dadgostar, R. Azani, and P. Maisonneuve, A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis, Canadian journal of public health, vol.92, p.281, 2001.

G. Defer,

M. Debouverie, La Sclérose en Plaques -Historique, épidémiologie et Pathogénie, 2019.

D. S. Goodin and D. Bates, Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode, Mult Scler, vol.15, pp.1175-1182, 2009.

D. S. Goodin, M. Corwin, D. Kaufman, H. Golub, S. Reshef et al., Causes of Death among Commercially Insured Multiple LES RÉFÉRENCES BIBLIOGRAPHIQUES, 2014.

D. Socio-Économiques and . Sep, Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER Sclerosis Patients in the United States, PLoS ONE, vol.9

R. Goulden, T. Ibrahim, and C. Wolfson, Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review, Eur J Neurol, vol.22, pp.899-911, 2015.

R. Goulden, T. Riise, K. Myhr, M. Pugliatti, and C. Wolfson, Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study, Eur J Neurol, 2015.

S. Greenland and H. Morgenstern, Ecological Bias, Confounding, and Effect Modification, Int. J. Epidemiol, vol.18, pp.269-274, 1989.

L. M. Grimaldi, B. Palmeri, G. Salemi, G. Giglia, M. D'amelio et al., High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Neuroepidemiology, vol.28, pp.28-32, 2007.

S. A. Grønlie, E. Myrvoll, G. Hansen, M. Grønning, and S. I. Mellgren, Multiple sclerosis in North Norway, and first appearance in an indigenous population, J. Neurol, vol.247, pp.129-133, 2000.

N. Grytten-torkildsen, S. A. Lie, J. H. Aarseth, H. Nyland, and K. M. Myhr, Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway, Mult Scler, vol.14, pp.1191-1199, 2008.

E. Guillaume, C. Pornet, O. Dejardin, L. Launay, R. Lillini et al., Development of a cross-cultural deprivation index in five European countries, J Epidemiol Community Health, vol.70, pp.493-499, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02367141


J. Halper and J. S. Burks, Care patterns in multiple sclerosis: principal care, comprehensive team care, consortium care, NeuroRehabilitation, vol.4, pp.67-75, 1994.


F. J. Hans, L. Wei, D. Bereczki, V. Acuff, J. Demaro et al., Nicotine increases microvascular blood flow and flow velocity in three groups of brain areas, Am. J. Physiol, vol.265, pp.2142-2150, 1993.

K. E. Harding, M. Wardle, R. Carruthers, N. Robertson, F. Zhu et al., Socioeconomic status and disability progression in multiple sclerosis: A multinational study, Neurology, vol.92, pp.1-10, 2019.


S. Havard, S. Deguen, J. Bodin, K. Louis, O. Laurent et al., A small-area index of socioeconomic deprivation to capture health inequalities in France, Soc Sci Med, vol.67, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00672312

B. C. Healy, E. N. Ali, C. R. Guttmann, T. Chitnis, B. I. Glanz et al., Smoking and disease progression in multiple sclerosis, Arch. Neurol, vol.66, pp.858-864, 2009.

A. K. Hedström, M. Bäärnhielm, T. Olsson, and L. Alfredsson, Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis, Neurology, vol.73, pp.696-701, 2009.

A. K. Hedström, T. Olsson, and L. Alfredsson, Body mass index during adolescence, rather than childhood, is critical in determining MS risk, Mult Scler, vol.22, pp.878-883, 2016.

A. K. Hedström, T. Olsson, and L. Alfredsson, Smoking is a major preventable risk factor for multiple sclerosis, Mult Scler, 2015.

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

A. K. Hedström, T. Olsson, and L. Alfredsson, High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women, Multiple Sclerosis Journal, vol.18, pp.1334-1336, 2012.

A. K. Hedström, M. Ryner, K. Fink, A. Fogdell-hahn, L. Alfredsson et al., Smoking and risk of treatment-induced neutralizing antibodies to interferon ?-1a, Mult Scler, vol.20, pp.445-450, 2014.

A. K. Hedström, E. Sundqvist, M. Bäärnhielm, N. Nordin, J. Hillert et al., Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis, Brain, vol.134, pp.653-64, 2011.


M. A. Hernán, S. S. Jick, G. Logroscino, M. J. Olek, A. Ascherio et al., Cigarette smoking and the progression of multiple sclerosis, Brain, vol.128, pp.1461-1465, 2005.

M. A. Hernán, M. J. Olek, and A. Ascherio, Cigarette smoking and incidence of multiple sclerosis, Am. J. Epidemiol, vol.154, pp.69-74, 2001.

J. A. Hollenbach and J. R. Oksenberg, The immunogenetics of multiple sclerosis: A comprehensive review, J. Autoimmun, vol.64, pp.13-25, 2015.


S. Hucke, H. Wiendl, and L. Klotz, Implications of dietary salt intake for multiple sclerosis pathogenesis, Multiple Sclerosis Journal, vol.22, pp.133-139, 2016.

, Situation cancer France, 2012.

, La couverture complémentaire santé en France dans ESPS : Données générales. IRDES. Institut de Recherche et Documentation en Economie de la Santé, IRDES, 2013.

N. Jafari and R. Q. Hintzen, The association between cigarette smoking and multiple sclerosis, European Charcot Foundation SymposiumA Reappraisal of Nutrition and Environment in Multiple SclerosisEuropean Charcot Foundation Symposium, vol.311, pp.78-85, 2011.


C. B. Kamphuis, G. Turrell, K. Giskes, J. P. Mackenbach, and F. J. Van-lenthe, Socioeconomic inequalities in cardiovascular mortality and the role of childhood socioeconomic conditions and adulthood risk factors: a prospective cohort study with 17-years of follow up, BMC Public Health, vol.12, 2012.

W. B. Kannel, R. B. Agostino, and A. J. Belanger, Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study, Am. Heart J, vol.113, pp.1006-1010, 1987.

M. Karvonen, J. Tuomilehto, J. Pitkäniemi, A. Naukkarinen, and P. Saikku, Importance of smoking for Chlamydia pneumoniae seropositivity, Int J Epidemiol, vol.23, pp.1315-1321, 1994.

K. S. Kavak, B. E. Teter, J. Hagemeier, K. Zakalik, B. Weinstock-guttman et al., Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset, Mult Scler, vol.21, pp.858-865, 2015.

A. D. Keita, S. E. Judd, V. J. Howard, A. P. Carson, J. D. Ard et al., Associations of neighborhood area level deprivation with the metabolic syndrome and inflammation among middle-and older-age adults, BMC Public Health, vol.14, pp.13-19, 2014.

S. B. Kelly, E. Chaila, K. Kinsella, M. Duggan, C. Mcguigan et al., Multiple sclerosis, from referral to confirmed diagnosis: an audit of clinical practice, Mult Scler, vol.17, pp.1017-1021, 2011.

. Les and . Bibliographiques,

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

M. Kleinewietfeld, A. Manzel, J. Titze, H. Kvakan, N. Yosef et al., Sodium Chloride Drives Autoimmune Disease by the Induction of Pathogenic Th17 Cells, Nature, vol.496, pp.518-522, 2013.

A. J. Knighton, Is a Patient's Current Address of Record a Reasonable Measure of Neighborhood Deprivation Exposure? A Case for the Use of Point in Time Measures of Residence in Clinical Care, Health Equity, vol.2, pp.62-69, 2018.


N. Krieger, Embodiment: a conceptual glossary for epidemiology, Journal of Epidemiology and Community Health, vol.59, 2005.

N. Krieger, Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology, Am J Public Health, vol.82, pp.703-710, 1992.

D. Kuh and Y. B. Shlomo, A Life Course Approach to Chronic Disease Epidemiology, 2004.

J. F. Kurtzke and W. F. Page, Epidemiology of multiple sclerosis in US veterans VII. Risk factors for MS, Neurology, vol.48, pp.204-213, 1997.

S. S. Kvistad, K. Myhr, T. Holmøy, J. ?altyt?-benth, S. Wergeland et al., Body mass index influence interferon-beta treatment response in multiple sclerosis, Journal of Neuroimmunology, vol.288, pp.92-97, 2015.

S. Lamy, F. Molinié, L. Daubisse-marliac, A. Cowppli-bony, S. Ayrault-piault et al., Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individuallevel measures: inequalities in breast cancer stage at diagnosis as an example, BMC Public Health, vol.19, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02299053

E. Landfeldt, A. Castelo-branco, A. Svedbom, E. Löfroth, A. Kavaliunas et al., The long-term impact of multiple sclerosis on the risk of divorce, Mult Scler Relat Disord, vol.24, pp.145-150, 2018.

L. Page, E. Veillard, D. Laplaud, D. A. Hamonic, S. Wardi et al., Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial, The Lancet, vol.386, pp.974-981, 2015.

U. Leibowitz, A. Antonovsky, J. M. Medalie, H. A. Smith, L. Halpern et al., Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation, Neurosurgery & Psychiatry, vol.29, pp.60-68, 1966.

L. M. Leijser, A. Siddiqi, and S. P. Miller, Imaging Evidence of the Effect of Socio-Economic Status on Brain Structure and Development, Semin Pediatr Neurol, vol.27, pp.26-34, 2018.

E. Leray, S. Vukusic, M. Debouverie, M. Clanet, B. Brochet et al., Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study, PLoS ONE, vol.10, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01201656

E. Leray, J. Yaouanq, E. Le-page, M. Coustans, D. Laplaud et al., Evidence for a two-stage disability progression in multiple sclerosis, Brain, vol.133, pp.1900-1913, 2010.

J. Lorscheider, K. Buzzard, V. Jokubaitis, T. Spelman, E. Havrdova et al.,

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

P. Grammond, R. Hupperts, R. Alroughani, P. Sola, C. Boz et al., Defining secondary progressive multiple sclerosis, Brain, vol.139, pp.2395-2405, 2016.

E. B. Loucks, J. W. Lynch, L. Pilote, R. Fuhrer, N. D. Almeida et al., Life-Course Socioeconomic Position and Incidence of Coronary Heart Disease: The Framingham Offspring Study, American Journal of Epidemiology, vol.169, pp.829-836, 2009.

F. D. Lublin, New Multiple Sclerosis Phenotypic Classification, European Neurology, vol.72, pp.1-5, 2014.

F. D. Lublin, S. C. Reingold, and . Others, Defining the clinical course of multiple sclerosis results of an international survey, Neurology, vol.46, pp.907-911, 1996.

E. B. Lugli, R. E. Correia, R. Fischer, K. Lundberg, K. R. Bracke et al., Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis, Arthritis Res. Ther, vol.17, 2015.

J. P. Mackenbach, I. Stirbu, A. J. Roskam, M. M. Schaap, G. Menvielle et al., Socioeconomic inequalities in health in 22 European countries, N Engl J Med, vol.358, pp.2468-81, 2008.


J. P. Mackenbach and K. Stronks, The development of a strategy for tackling health inequalities in the Netherlands, Int J Equity Health, vol.3, 2004.

S. Magalhaes, M. Pugliatti, I. Casetta, J. Drulovic, E. Granieri et al., The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis, NED, vol.44, pp.173-181, 2015.

M. Magyari, N. Koch-henriksen, C. C. Pfleger, and P. S. Sørensen, Physical and social environment and the risk of multiple sclerosis, Multiple Sclerosis and Related Disorders, vol.3, pp.600-606, 2014.

D. Makrygiannakis, M. Hermansson, A. Ulfgren, A. P. Nicholas, A. J. Zendman et al., Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells, Ann. Rheum. Dis, vol.67, pp.1488-1492, 2008.


S. L. Mann, M. E. Wadsworth, and J. R. Colley, Accumulation of factors influencing respiratory illness in members of a national birth cohort and their offspring, J Epidemiol Community Health, vol.46, pp.286-292, 1992.

A. Manouchehrinia, R. Tanasescu, C. R. Tench, and C. S. Constantinescu, Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios, Neurosurgery & Psychiatry, vol.87, pp.324-331, 2016.

A. Manouchehrinia, H. Westerlind, E. Kingwell, F. Zhu, R. Carruthers et al., Age related multiple sclerosis severity score: Disability ranked by age, Multiple Sclerosis Journal, vol.23, pp.1938-1946, 2017.

A. Manouchehrinia, M. Weston, C. R. Tench, J. Britton, and C. S. Constantinescu, Tobacco smoking and excess mortality in multiple sclerosis: a cohort study, J Neurol Neurosurg Psychiatry, vol.85, pp.1091-1095, 2014.

. Les and . Bibliographiques,

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

R. A. Marrie, G. Cutter, T. Tyry, T. Vollmer, and D. Campagnolo, Does multiple sclerosisassociated disability differ between races?, Neurology, vol.66, pp.1235-1240, 2006.

R. A. Marrie, R. Horwitz, G. Cutter, T. Tyry, D. Campagnolo et al., Comorbidity delays diagnosis and increases disability at diagnosis in MS, Neurology, vol.72, pp.117-124, 2009.

R. A. Marrie, R. Horwitz, G. Cutter, T. Tyry, D. Campagnolo et al., Comorbidity, socioeconomic status and multiple sclerosis, Mult Scler, vol.14, pp.1091-1098, 2008.

J. Masdonati and T. Zittoun, Les transitions professionnelles: Processus psychosociaux et implications pour le conseil en orientation. L'orientation scolaire et professionnelle, 2012.

D. Mcalpine and N. Compston, Some aspects of the natural history of disseminated sclerosis, Q. J. Med, vol.21, pp.135-167, 1952.

W. I. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. P. Hartung et al., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, Ann. Neurol, vol.50, pp.121-127, 2001.

E. Mcfadden, M. C. Horton, H. L. Ford, G. Gilworth, M. Mcfadden et al., Screening for the risk of job loss in multiple sclerosis (MS): development of an MSspecific Work Instability Scale (MS-WIS), Mult. Scler, vol.18, pp.862-870, 2012.

Y. Mikaeloff, G. Caridade, M. Tardieu, and S. Suissa, Parental smoking at home and the risk of childhood-onset multiple sclerosis in children, Brain, vol.130, pp.2589-2595, 2007.

D. Miller, F. Barkhof, X. Montalban, A. Thompson, and M. Filippi, Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis, The Lancet Neurology, vol.4, pp.281-288, 2005.

, , pp.70071-70076

G. E. Miller, E. Chen, A. K. Fok, H. Walker, A. Lim et al., Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling, Proceedings of the National Academy of Sciences of the United States of America, vol.106, 2009.

H. Miller, A. Ridley, and K. Schapira, Multiple Sclerosis, Br Med J, vol.2, pp.343-345, 1960.
URL : https://hal.archives-ouvertes.fr/hal-00652652

S. L. Minden, D. Frankel, L. Hadden, and D. C. Hoaglin, Access to health care for people with multiple sclerosis, Mult Scler, vol.13, pp.547-558, 2007.


S. L. Minden, D. C. Hoaglin, L. Hadden, D. Frankel, T. Robbins et al., Access to and utilization of neurologists by people with multiple sclerosis, Neurology, vol.70, pp.1141-1149, 2008.

M. Minkler, E. Fuller-thomson, and J. M. Guralnik, Gradient of Disability across the Socioeconomic Spectrum in the United States, New England Journal of Medicine, vol.355, pp.695-703, 2006.

B. Mitrovic, J. Parkinson, and J. E. Merrill, An in Vitro Model of Oligodendrocyte Destruction by Nitric Oxide and Its Relevance to Multiple Sclerosis, Methods, vol.10, pp.501-513, 1996.

M. Thibault,

R. Du-pasquier, , 2018.

R. Morris and V. Carstairs, Which deprivation? A comparison of selected deprivation indexes, J Public Health, vol.13, pp.318-326, 1991.

P. Moszczy?ski, Z. Zabi?ski, P. Moszczy?ski, J. Rutowski, S. S?owi?ski et al., Immunological findings in cigarette smokers, Toxicol. Lett, vol.118, pp.121-127, 2001.

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

R. Motl and E. Mcauley, Association between change in physical activity and short-term disability progression in multiple sclerosis, Journal of Rehabilitation Medicine, vol.43, pp.305-310, 2011.

K. Munger, J. Bentzen, B. Laursen, E. Stenager, N. Koch-henriksen et al., Childhood body mass index and multiple sclerosis risk: a long-term cohort study, Mult Scler, vol.19, pp.1323-1329, 2013.

C. Muntaner, C. Borrell, J. Benach, M. I. Pasarín, and E. Fernandez, The associations of social class and social stratification with patterns of general and mental health in a Spanish population, Int J Epidemiol, vol.32, pp.950-958, 2003.

C. A. Mustard, S. Derksen, J. Berthelot, and M. Wolfson, Assessing ecologic proxies for household income: a comparison of household and neighbourhood level income measures in the study of population health status, Health & Place, vol.5, pp.157-171, 1999.

J. Y. Nazroo, The structuring of ethnic inequalities in health: economic position, racial discrimination, and racism, Am J Public Health, vol.93, pp.277-284, 2003.

R. D. Neal, P. Tharmanathan, B. France, N. U. Din, S. Cotton et al., Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review, Br J Cancer, vol.112, pp.92-107, 2015.

N. M. Nielsen, K. T. Jørgensen, P. Bager, E. Stenager, B. V. Pedersen et al., Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis, Am. J. Epidemiol, vol.177, pp.1289-1295, 2013.


K. Noyes and B. Weinstock-guttman, Impact of diagnosis and early treatment on the course of multiple sclerosis, Am J Manag Care, vol.19, pp.321-331, 2013.

P. W. O'connor, J. S. Wolinsky, K. Thangavelu, P. Truffinet, P. Rufi et al., Reduced risk of disability progression in patients with MS treated with early vs delayed Teriflunomide 14 mg, 2015.

J. R. Oksenberg and S. E. Baranzini, Multiple sclerosis genetics-is the glass half full, or half empty?, Nature Reviews Neurology, vol.6, pp.429-437, 2010.


S. Olsson, Diffusion, utilisation and regional variations in the use of CT and MRI in Sweden, vol.66, pp.129-135, 2001.

, Combler le fossé en une génération: instaurer l'équité en santé en agissant sur les déterminants sociaux de la santé : rapport final, 2009.

T. Owens, N. Evangelou, and D. K. Whynes, Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom, Eur J Health Econ, vol.14, pp.315-336, 2013.

R. Pampalon, D. Hamel, and P. Gamache, A comparison of individual and area-based socioeconomic data for monitoring social inequalities in health, Health Rep, vol.20, pp.85-94, 2009.

R. Pampalon, D. Hamel, P. Gamache, M. D. Philibert, G. Raymond et al., An area-based material and social deprivation index for public health in Québec and Canada, Can J Public Health, vol.103, pp.17-22, 2012.

R. Pampalon, D. Hamel, P. Gamache, A. Simpson, and M. D. Philibert, Validation of a deprivation index for public health: a complex exercise illustrated by the Quebec index, Chronic Dis Inj Can, vol.34, pp.12-22, 2014.

F. C. Pampel and R. G. Rogers, Socioeconomic status, smoking, and health: a test of competing theories of cumulative advantage, J Health Soc Behav, vol.45, pp.306-321, 2004.

E. R. Petersen, A. B. Oturai, N. Koch-henriksen, M. Magyari, P. S. Sørensen et al., Smoking affects the interferon beta treatment response in LES RÉFÉRENCES BIBLIOGRAPHIQUES, 2018.

D. Socio-Économiques and . Sep, Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER multiple sclerosis, Neurology, vol.90, pp.593-600


D. B. Petitti and H. Kipp, The leukocyte count: associations with intensity of smoking and persistence of effect after quitting, Am. J. Epidemiol, vol.123, pp.89-95, 1986.

D. J. Philbrick, J. B. Hopkins, D. C. Hill, J. C. Alexander, and R. G. Thomson, Effects of prolonged cyanide and thiocyanate feeding in rats, J Toxicol Environ Health, vol.5, pp.579-592, 1979.

M. D. Philibert, R. Pampalon, D. Hamel, and M. Daniel, Associations between disability prevalence and local-area characteristics in a general community-living population. Revue d'Épidémiologie et de Santé Publique 61, pp.463-474, 2013.


M. D. Philibert, R. Pampalon, D. Hamel, and M. Daniel, Interactions between neighborhood characteristics and individual functional status in relation to disability among Québec urbanites, Disabil Health J, vol.6, pp.361-368, 2013.


C. Pierrot-deseilligny, Clinical implications of a possible role of vitamin D in multiple sclerosis, Journal of Neurology, vol.256, pp.1468-1479, 2009.

S. A. Pietras and E. Goodman, Socioeconomic status gradients in inflammation in adolescence, Psychosom Med, vol.75, pp.442-448, 2013.


J. Pike, E. Jones, K. Rajagopalan, J. Piercy, and P. Anderson, Social and economic burden of walking and mobility problems in multiple sclerosis, BMC Neurol, vol.12, 2012.

F. Pittas, A. Ponsonby, I. A. Mei, B. V. Taylor, L. Blizzard et al., Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis, Journal of Neurology, vol.256, pp.577-585, 2009.

L. Plantinga, K. Johansen, D. Schillinger, and N. Powe, Lower Socioeconomic Status and Disability Among US Adults With Chronic Kidney Disease, Preventing Chronic Disease, 1999.

C. H. Polman, S. C. Reingold, B. Banwell, M. Clanet, J. A. Cohen et al., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Ann Neurol, vol.69, pp.292-302, 2011.

C. H. Polman, S. C. Reingold, G. Edan, M. Filippi, H. Hartung et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria, Ann Neurol, vol.58, pp.840-846, 2005.


C. Pornet, C. Delpierre, O. Dejardin, P. Grosclaude, L. Launay et al., Construction of an adaptable European transnational ecological deprivation index: the French version, J Epidemiol Community Health, vol.66, pp.982-991, 2012.

C. Pornet, B. Denis, P. Perrin, I. Gendre, and G. Launoy, Predictors of adherence to repeat fecal occult blood test in a population-based colorectal cancer screening program, Br. J. Cancer, vol.111, pp.2152-2155, 2014.

C. M. Poser, D. W. Paty, L. Scheinberg, W. I. Mcdonald, F. A. Davis et al., New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann Neurol, vol.13, pp.227-258, 1983.

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

L. Potvin, C. M. Jones, and M. Moquet, Réduire les inégalités sociales en santé. Institut national de prévention et d'éducation pour la santé, 2012.

C. Power, S. Matthews, and O. Manor, Inequalities in self rated health in the 1958 birth cohort: lifetime social circumstances or social mobility?, BMJ, vol.313, pp.449-453, 1996.

C. Probst, L. C. Simbayi, C. D. Parry, P. A. Shuper, and J. Rehm, Alcohol Use, Socioeconomic Status and Risk of HIV Infections, AIDS and Behavior, vol.21, pp.1926-1937, 2017.

M. Pugliatti, I. Casetta, J. Drulovic, E. Granieri, T. Holmøy et al., A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q), Acta Neurol Scand, vol.126, pp.43-50, 2012.

E. Puolakka, K. Pahkala, T. T. Laitinen, C. G. Magnussen, N. Hutri-kähönen et al., Childhood socioeconomic status and lifetime health behaviors: The Young Finns Study, Int. J. Cardiol, vol.258, pp.289-294, 2018.

W. Qian, T. A. Schweizer, and C. E. Fischer, Impact of socioeconomic status on initial clinical presentation to a memory disorders clinic, Int Psychogeriatr, vol.26, pp.597-603, 2014.

P. Ragonese, P. Aridon, G. Salemi, M. D'amelio, and G. Savettieri, Mortality in multiple sclerosis: a review, European Journal of Neurology, vol.15, pp.123-127, 2008.


S. Ramachandran, R. C. Strange, P. W. Jones, S. Kalra, D. Nayak et al., Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model, Multiple Sclerosis and Related Disorders, vol.3, pp.593-599, 2014.

R. Ramanujam, A. Hedstrom, A. Manouchehrinia, L. Alfredsson, T. M. Olsson et al., Effect of Smoking Cessation on Multiple Sclerosis Prognosis, JAMA Neurology, vol.72, pp.1117-1123, 2015.

K. Rejdak, M. J. Eikelenboom, A. Petzold, E. J. Thompson, Z. Stelmasiak et al., CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis, Neurology, vol.63, pp.1439-1445, 2004.

G. Rey, E. Jougla, A. Fouillet, and D. Hémon, Ecological association between a deprivation index and mortality in France over the period 1997 -2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death, BMC Public Health, vol.9, 2009.

C. Ribet, M. Melchior, T. Lang, M. Zins, M. Goldberg et al., Characterisation and measurement of social position in epidemiologic studies, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00165600

, Rev Epidemiol Sante Publique, vol.55, pp.285-295

T. Riise, J. Kirkeleit, J. H. Aarseth, E. Farbu, R. Midgard et al., Risk of MS is not associated with exposure to crude oil, but increases with low level of education, Mult. Scler, vol.17, pp.780-787, 2011.

T. Riise, M. W. Nortvedt, and A. Ascherio, Smoking is a risk factor for multiple sclerosis, Neurology, vol.61, pp.1122-1124, 2003.

C. S. Robbins, D. E. Dawe, S. I. Goncharova, M. A. Pouladi, A. G. Drannik et al., Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness, Am. J. Respir. Cell Mol. Biol, vol.30, pp.202-211, 2004.

. Les and . Bibliographiques,

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

H. Roddam, D. Rog, J. Janssen, N. Wilson, L. Cross et al., Inequalities in access to health and social care among adults with multiple sclerosis: A scoping review of the literature, Mult Scler Relat Disord, vol.28, pp.290-304, 2019.


I. Romon, G. Rey, L. Mandereau-bruno, A. Weill, E. Jougla et al., The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort, Diabet. Med, vol.31, pp.946-953, 2014.

S. A. Roudbari, M. M. Ansar, and A. Yousefzad, Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan, Journal of the Neurological Sciences, vol.330, pp.52-55, 2013.

W. R. Russell, Multiple sclerosis: occupation and social group at onset, The Lancet, vol.298, pp.832-834, 1971.

A. R. Salter, G. R. Cutter, T. Tyry, R. A. Marrie, and T. Vollmer, Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS, Curr Med Res Opin, vol.26, pp.493-500, 2010.

F. Santé-publique, Rapport outils elabores cadre programme inegalites sociales sante, 2013.

A. Scalfari, V. Knappertz, G. Cutter, D. S. Goodin, R. Ashton et al., Mortality in patients with multiple sclerosis, Neurology, vol.81, pp.184-92, 2013.


A. Scalfari, V. Knappertz, G. Cutter, D. S. Goodin, R. Ashton et al., Mortality in patients with multiple sclerosis, Neurology, vol.81, pp.184-192, 2013.

A. Scalfari, C. Lederer, M. Daumer, R. Nicholas, G. Ebers et al., The relationship of age with the clinical phenotype in multiple sclerosis, Multiple Sclerosis Journal, vol.22, pp.1750-1758, 2016.

A. Scalfari, A. Neuhaus, M. Daumer, G. C. Deluca, P. A. Muraro et al., Early relapses, onset of progression, and late outcome in multiple sclerosis, JAMA Neurol, vol.70, pp.214-222, 2013.

A. Scalfari, A. Neuhaus, M. Daumer, G. C. Ebers, and P. A. Muraro, Age and disability accumulation in multiple sclerosis, Neurology, vol.77, pp.1246-1252, 2011.

A. Scalfari, A. Neuhaus, M. Daumer, P. A. Muraro, and G. C. Ebers, Onset of secondary progressive phase and long-term evolution of multiple sclerosis, J. Neurol. Neurosurg. Psychiatr, vol.85, pp.67-75, 2014.

N. Schmitz, D. Nitka, G. Gariepy, A. Malla, J. Wang et al., Association Between Neighborhood-Level Deprivation and Disability in a Community Sample of People With Diabetes, Diabetes Care, vol.32, 1998.

G. A. Schumacher, G. Beebe, R. F. Kibler, L. T. Kurland, J. F. Kurtzke et al., Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis, Ann. N. Y. Acad. Sci, vol.122, pp.552-568, 1965.

N. J. Scolding, M. Pasquini, S. C. Reingold, and J. A. Cohen, Cell-based therapeutic strategies for multiple sclerosis, International Conference on Cell-Based Therapies for Multiple Sclerosis, International Conference on Cell-Based Therapies for Multiple Sclerosis, International Conference on Cell-Based Therapies for Multiple Sclerosis, vol.140, pp.2776-2796, 2017.

B. Serafini, B. Rosicarelli, D. Franciotta, R. Magliozzi, R. Reynolds et al., Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain, J Exp Med, vol.204, pp.2899-2912, 2007.

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

K. Sharif, H. Amital, and Y. Shoenfeld, The role of dietary sodium in autoimmune diseases: The salty truth, Autoimmunity Reviews, vol.17, pp.1069-1073, 2018.


Y. Sidhom, E. Maillart, S. Tezenas-du-montcel, I. Kacem, C. Lubetzki et al., Fast multiple sclerosis progression in North Africans: Both genetics and environment matter, Neurology, vol.88, pp.1218-1225, 2017.


G. K. Singh, Area deprivation and widening inequalities in US mortality, Am J Public Health, vol.93, pp.1137-1143, 2003.

A. Singh-manoux, Socioeconomic trajectories across the life course and health outcomes in midlife: evidence for the accumulation hypothesis?, International Journal of Epidemiology, vol.33, pp.1072-1079, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-01154207

G. D. Smith, C. Hart, D. Blane, and D. Hole, Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study, BMJ, vol.316, pp.1631-1635, 1998.

K. J. Smith, R. Kapoor, and P. A. Felts, Demyelination: the role of reactive oxygen and nitrogen species, Brain Pathol, vol.9, pp.69-92, 1999.

P. Sundström, L. Nyström, and G. Hallmans, Smoke exposure increases the risk for multiple sclerosis, Eur. J. Neurol, vol.15, pp.579-583, 2008.

H. Tedeholm, J. Lycke, B. Skoog, V. Lisovskaja, J. Hillert et al., Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs, Mult Scler, vol.19, pp.765-774, 2013.


A. J. Thompson, B. L. Banwell, F. Barkhof, W. M. Carroll, T. Coetzee et al., Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria, The Lancet Neurology, vol.17, pp.162-173, 2018.

M. Tintore, S. Otero-romero, J. Río, G. Arrambide, B. Pujal et al., Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis, Neurology, vol.87, pp.1368-1374, 2016.

M. Touraine, Health inequalities and France's national health strategy, Lancet, vol.383, pp.1101-1102, 2014.

M. Touraine, H. Gröhe, R. G. Coffie, S. Sathasivam, M. Juan et al., Universal health coverage and the post-2015 agenda, Lancet, vol.384, pp.61419-61426, 2014.

P. Townsend, Deprivation, Journal of Social Policy, vol.16, 1987.

R. P. Tracy, B. M. Psaty, E. Macy, E. G. Bovill, M. Cushman et al., Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects, Arterioscler. Thromb. Vasc. Biol, vol.17, pp.2167-2176, 1997.

K. Treadaway, G. Cutter, A. Salter, S. Lynch, J. Simsarian et al.,

M. Frohman and E. M. , Factors that influence adherence with disease-modifying therapy in MS, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER, vol.256, pp.568-576, 2009.

L. Tron, A. Belot, M. Fauvernier, L. Remontet, N. Bossard et al., French Network of Cancer Registries (FRANCIM), 2019. Socioeconomic environment and disparities in cancer survival for 19 solid tumor sites: An analysis of the French Network of Cancer Registries (FRANCIM) data, Int. J. Cancer, vol.144, pp.1262-1274

P. Tuppin, P. Ricci-renaud, C. De-peretti, A. Fagot-campagna, C. Gastaldi-menager et al., Antihypertensive, antidiabetic and lipidlowering treatment frequencies in France in 2010, Arch Cardiovasc Dis, vol.106, pp.274-286, 2013.

G. Turrell and C. Mathers, Socioeconomic inequalities in all-cause and specific-cause mortality in Australia: 1985-1987 and 1995-1997, Int J Epidemiol, vol.30, pp.231-239, 2001.

J. Vallée, The daycourse of place, Soc Sci Med, vol.194, pp.177-181, 2017.

M. Van-ham and D. Manley, Neighbourhood Effects Research at a Crossroads. Ten Challenges for Future Research Introduction, Environ Plan A, vol.44, pp.2787-2793, 2012.

M. Van-ham, T. Tammaru, E. De-vuijst, and M. Zwiers, Spatial Segregation and Socio-Economic Mobility in European Cities 23

B. R. Visscher, V. A. Clark, R. Detels, R. M. Malmgren, N. L. Valdiviezo et al., Two populations with multiple sclerosis, Journal of neurology, vol.225, pp.237-249, 1981.

S. Vukusic, R. Casey, F. Rollot, B. Brochet, J. Pelletier et al., Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France, Mult. Scler, pp.1-5, 2018.


S. Vukusic and C. Confavreux, Histoire naturelle de la sclérose en plaques. La Presse Médicale, Maladies démyélinisantes du système nerveux, vol.39, pp.359-362, 2010.

S. Vukusic, V. Van-bockstael, S. Gosselin, and C. Confavreux, Regional variations in the prevalence of multiple sclerosis in French farmers, J Neurol Neurosurg Psychiatry, vol.78, pp.707-709, 2007.

E. U. Walther and R. Hohlfeld, Multiple sclerosis: side effects of interferon beta therapy and their management, Neurology, vol.53, pp.1622-1627, 1999.

N. U. Weir, A. Gunkel, M. Mcdowall, and M. S. Dennis, Study of the relationship between social deprivation and outcome after stroke, Stroke, vol.36, pp.815-819, 2005.

M. Wendel-haga and E. G. Celius, Is the hygiene hypothesis relevant for the risk of multiple sclerosis?, Acta Neurologica Scandinavica, vol.136, pp.26-30, 2017.


K. Wesnes, T. Riise, I. Casetta, J. Drulovic, E. Granieri et al., Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study, Mult Scler, vol.21, pp.388-395, 2015.

K. M. Wheeler, T. Antoniou, S. Gardner, L. Light, R. Grewal et al., Sociodemographic and Health Profile of Heterosexual Men Living With HIV in Ontario, Canada, Am J Mens Health, vol.11, pp.855-862, 2017.

, Déterminants Socio-Économiques et SEP : Influence sur l'évolution et la prise en charge thérapeutique Dr Floriane CALOCER

C. R. Wicks, K. Ward, A. Stroud, A. Tennant, and H. L. Ford, Multiple sclerosis and employment: Associations of psychological factors and work instability, J Rehabil Med, vol.48, pp.799-805, 2016.

J. M. Wijnands, O. Ekuma, E. Kingwell, F. Zhu, Y. Zhao et al., MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis, Multiple Sclerosis and Related Disorders, vol.28, pp.138-144, 2019.

S. Willems, S. De-maesschalck, M. Deveugele, A. Derese, and J. De-maeseneer, Socioeconomic status of the patient and doctor-patient communication: does it make a difference?, Patient Education and Counseling, vol.56, pp.139-146, 2005.


C. J. Willer, D. A. Dyment, N. J. Risch, A. D. Sadovnick, G. C. Ebers et al., Twin concordance and sibling recurrence rates in multiple sclerosis, Proceedings of the National Academy of Sciences, vol.100, pp.12877-12882, 2003.

M. J. Williams, K. Johnson, H. M. Trenz, S. Korrer, R. Halpern et al., Adherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetate, Curr Med Res Opin, vol.34, pp.107-115, 2018.

, Guideline. World Health Organization, Place of publication not identified, World Health Organization, 2016.

J. Zeitlin, E. Combier, M. Levaillant, L. Lasbeur, H. Pilkington et al., Neighbourhood socio-economic characteristics and the risk of preterm birth for migrant and non-migrant women: a study in a French district, Paediatr Perinat Epidemiol, vol.25, pp.347-356, 2011.
URL : https://hal.archives-ouvertes.fr/halshs-00726488

Y. Zhou, S. Simpson, A. F. Holloway, J. Charlesworth, I. Mei et al., The potential role of epigenetic modifications in the heritability of multiple sclerosis, Mult Scler, vol.20, pp.135-140, 2014.

T. Ziemssen, N. De-stefano, M. Pia-sormani, B. Van-wijmeersch, H. Wiendl et al., Optimizing therapy early in multiple sclerosis: An evidence-based view, Multiple Sclerosis and Related Disorders, vol.4, pp.460-469, 2015.


N. Zilber and E. Kahana, Risk factors for multiple sclerosis: a case-control study in Israel, Acta Neurologica Scandinavica, vol.94, pp.395-403, 1996.

R. Zivadinov, B. Weinstock-guttman, K. Hashmi, N. Abdelrahman, M. Stosic et al., Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis, Neurology, vol.73, pp.504-510, 2009.